Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…the efficacy and safety of two cycles of induction therapy with bevacizumab and paclitaxel followed by atezolizumab and nab-paclitaxel comp…
…). The drugs considered most difficult to prepare manually were paclitaxel (35%), fluorouracil (13%), and cyclophosphamide (12%), while th…
…64.4%) AT and 25 (55.6%) HP.The AT most frequently involved was paclitaxel (50; 11.3%), followed by cyclophosphamide (37; 8.4%), doxorubic…
…umab) are often used in ovarian and cervical cancers. ICIs (eg, pembrolizumab) are effective in mismatch repair-deficient endometrial cancer …
…up patients will receive ≥5 min balloon dilation with localised paclitaxel delivery. The control group will receive standard endoscopic tr…
…t related adverse events was 66.7% (269 of 403 patients) in the carboplatin arm and 55.0% (222 of 404 patients) in the control arm. No trea…
…h all patient biopsies, achieving the primary endpoint. Ex-vivo pembrolizumab response rate was 14% (2 of 14 samples evaluated thus far), whi…
… IP PTX efficacy.Conclusions These results demonstrated that IP paclitaxel reprograms peritoneal macrophages and DCs toward pro-inflammato…
…oxygenation strategies remain limited for clinical translation. NanO 2 (NuvOx Pharma), a novel perfluorocarbon-based oxygen therapeuti…
…ion and potential as a therapeutic focus.Methods The potency of AVA-NP-695, a small-molecule ENPP1 inhibitor, was validated through enzyma…
…022 (22 )) DCB (84) DES (79) Sequent Please Resolute Integrity (Zotarolimus) or Xience(Everolimus) or Firehawk (rapamycin) 62.6±8.8 64.0±10…
…ocol (paclitaxel, carboplatin, epirubicin, cyclophosphamide and pembrolizumab). Following the sixth cycle, she developed refractory focal sei…